The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
We received an updated WNV package insert; please note the manufacturer and license number has been ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...